Learner Notification
International Society for the Study of Women's Sexual Health
2022 Fall Course
November 17 – 19, 2022
Scottsdale, AZ
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for the Study of Women's Sexual Health (ISSWSH). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME)
Amedco LLC designates this live activity for a maximum of 19.50 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AASECT
This program meets the requirements of the American Association of Sexuality Educators, Counselors and Therapists (AASECT) and is approved for 19.5 AASECT CE Credits. These CE Credits may be applied toward AASECT certification and renewal of certification.
Objectives - After Attending This Program You Should Be Able To
- Develop skills that allow for discussing sexual concerns with female patients.
- Cite the pathophysiology of hormonal, vascular and neurologic causes of sexual dysfunction in women.
- Describe the specific assessment for sexual dysfunction related to psychosexual factors.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
|
First |
Last |
Commercial Interest |
|
Karen |
Brandon |
NA |
|
Irwin |
Goldstein |
AbbVie:Research Grant Site Principal Investigator,Cynosure:Consultant,TRT:Speakers Bureau,Clarus:Speakers Bureau,Sprout:Consultant,TGI:Research Grant Site Principal Investigator,Solv Wellness:Research Grant Site Principal Investigator,Coloplast:Speakers Bureau,Endo:Scientific/Medical Advisory Board Member,SST:Research Grant Site Principal Investigator |
|
Sue |
Goldstein |
Cynosure:Consultant,Solv Wellness:Consultant |
|
Crista Elcira |
Johnson-Agbakwu |
Scynexis:Consultant |
|
Susan |
Kellogg-Spadt |
Materna:Consultant,Scynexis:Scientific/Medical Advisory Board Member,Good Clean Love:Scientific/Medical Advisory Board Member,Lupin:Scientific/Medical Advisory Board Member,Bonafide:Scientific/Medical Advisory Board Member,Dare:Consultant,Mystery Vibe:Consultant |
|
Sheryl |
Kingsberg |
Astellas:Consultant,Field Trip:Stock Shareholder,Field Trip:Consultant,Palatin Technologies, Inc.:Consultant,Pfizer, Lupin, Materna:Consultant,Dare:Research Grant Site Principal Investigator,dare:Consultant,TherapeuticsMD:Speakers Bureau,TherapeuticsMD:Consultant,Sprout:Consultant,Materna Medical:Stock Shareholder,Strategic Science Technologies:Consultant |
|
Sheryl |
Kingsberg |
Astellas, Bayer:Consultant,Field Trip, Alloy, Ms. Medicine, Viveve:Stock Shareholder,Field Trip:Consultant,Palatin Technologies, Inc.:Consultant,Pfizer, Materna:Consultant,Dare:Research Grant Site Principal Investigator,dare:Consultant,TherapeuticsMD:Speakers Bureau,TherapeuticsMD:Consultant,Sprout:Consultant,Materna Medical:Stock Shareholder,Strategic Science Technologies:Consultant |
|
Sharon |
Parish |
Dare Bioscience:Consultant,Ms. Medicine Provider Executive Group:Consultant,Roman Health Adventures:Consultant |
|
Tami |
Rowen |
RosyWellness:Consultant |
|
RS |
Rubin |
Sprout:Consultant,Absorption Pharmaceuticals:Scientific/Medical Advisory Board Member |
|
Tracy |
Sandstrom |
NA |
|
James |
Simon |
Bayer Healthcare, Besins Healthcare, California Institute of Integral Studies (CIIS), Dare Bioscience, DEKA M.E.L.A S.r.l., Femasys, KaNDy/NeRRe Therapeutics, Khyria, Madorra:Consultant,Mitsubishi Tanabe Pharma Development America, QUE Oncology, Scynexis Inc, Sprout Pharmaceuticals, Vella Bioscience:Consultant,Mayne Pharma, Myovant Sciences, Pfizer, Pharmavite, Scynexis, TherapeuticsMD.:Speakers Bureau,Sermonix Pharmaceuticals:Stock Shareholder,AbbVie, Bayer Healthcare, DareBioscience, Enteris BioPharma, Mylan/Viatris, Myovant Sciences, ObsEva, Viveve Medical:Research Grant Overall Principal Investigator |